172 related articles for article (PubMed ID: 2467224)
1. Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat.
Higgins GA; Bradbury AJ; Jones BJ; Oakley NR
Neuropharmacology; 1988 Oct; 27(10):993-1001. PubMed ID: 2467224
[TBL] [Abstract][Full Text] [Related]
2. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
3. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.
Higgins GA; Jones BJ; Oakley NR
Psychopharmacology (Berl); 1992; 106(2):261-7. PubMed ID: 1347954
[TBL] [Abstract][Full Text] [Related]
5. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Wieland S; Kreider MS; McGonigle P; Lucki I
Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
[TBL] [Abstract][Full Text] [Related]
6. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
7. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
Blier P; Serrano A; Scatton B
Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
[TBL] [Abstract][Full Text] [Related]
8. Differential behavioural activation following intra-raphe infusion of 5-HT1A receptor agonists.
Higgins GA; Elliott PJ
Eur J Pharmacol; 1991 Feb; 193(3):351-6. PubMed ID: 1675996
[TBL] [Abstract][Full Text] [Related]
9. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
Gilbert F; Dourish CT
Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
[TBL] [Abstract][Full Text] [Related]
10. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
Cervo L; Mocaër E; Bertaglia A; Samanin R
Neuropharmacology; 2000 Apr; 39(6):1037-43. PubMed ID: 10727714
[TBL] [Abstract][Full Text] [Related]
11. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
12. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons.
Sprouse JS; Aghajanian GK
Neuropharmacology; 1988 Jul; 27(7):707-15. PubMed ID: 2901680
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of 5-HT1A receptor agonists injected into the dorsal raphe nucleus of conscious rats.
Connor HE; Higgins GA
Eur J Pharmacol; 1990 Jun; 182(1):63-72. PubMed ID: 2144824
[TBL] [Abstract][Full Text] [Related]
14. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity.
Hillegaart V; Hjorth S
Eur J Pharmacol; 1989 Jan; 160(2):303-7. PubMed ID: 2527161
[TBL] [Abstract][Full Text] [Related]
15. (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists.
Sprouse JS; Aghajanian GK
Eur J Pharmacol; 1986 Sep; 128(3):295-8. PubMed ID: 2878817
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism.
Martin P; Beninger RJ; Hamon M; Puech AJ
Behav Brain Res; 1990 May; 38(2):135-44. PubMed ID: 2141988
[TBL] [Abstract][Full Text] [Related]
17. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.
Cervo L; Grignaschi G; Samanin R
Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
19. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
20. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.
Carli M; Samanin R
Psychopharmacology (Berl); 1988; 94(1):84-91. PubMed ID: 2894704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
